Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
Director departure
|
|
MedAvail Holdings, Inc. (MDVL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2023 |
4
| Doerr Mark Edward (CEO) has filed a Form 4 on MedAvail Holdings, Inc.|
Txns:
| Granted 125,000 options to buy
@ $8.3, valued at
$1M
Granted 125,000 restricted stock units
@ $0 |
|
| 08/21/2023 |
4
| Seabaugh Ramona (CFO) has filed a Form 4 on MedAvail Holdings, Inc.|
Txns:
| Granted 57,484 options to buy
@ $8.3, valued at
$477.1k
Granted 57,484 restricted stock units
@ $0 |
|
| 08/18/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
8-K
| Investor presentation, Quarterly results |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/14/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 06/29/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/29/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/29/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/16/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Submission of Matters to a Vote of Security Holders, Other Events &... |
| 05/19/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/18/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/18/2023 |
8-K
| Quarterly results |
| 05/08/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
| 05/04/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/17/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 04/17/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 04/13/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure Interactive Data |
| 04/06/2023 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits Interactive Data |
| 04/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/23/2023 |
4
| Seabaugh Ramona (CFO) has filed a Form 4 on MedAvail Holdings, Inc.|
Txns:
| Sold 3,287 shares
@ $0.307, valued at
$1k
|
|
| 03/15/2023 |
SC 13D/A
| Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. reports a 29.6% stake in MedAvail Holdings, Inc. |
| 03/15/2023 |
4
| ABG WTT-MedAvail Ltd (10% Owner) has filed a Form 4 on MedAvail Holdings, Inc.|
Txns:
| Bought 6,818,181 options to buy
@ $0.001, valued at
$6.8k
Bought 965,130 options to buy
@ $0.001, valued at
$965.1 |
|
| 03/14/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 03/13/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on MedAvail Holdings, Inc.|
Txns:
| Granted 38,916,562 options to buy
@ $0.001, valued at
$38.9k
Granted 38,916,562 options to buy
@ $0.001, valued at
$38.9k
|
|
| 03/07/2023 |
4
| Seabaugh Ramona (CFO) has filed a Form 4 on MedAvail Holdings, Inc.|
Txns:
| Sold 6,727 shares
@ $0.3366, valued at
$2.3k
|
|
| 03/07/2023 |
4
| Doerr Mark Edward (CEO) has filed a Form 4 on MedAvail Holdings, Inc.|
Txns:
| Sold 20,773 shares
@ $0.3262, valued at
$6.8k
Sold 72,785 shares
@ $0.3112, valued at
$22.7k
|
|
|
|
|